A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.
|ClinicalTrials.gov Identifier: NCT00645437|
Recruitment Status : Completed
First Posted : March 27, 2008
Last Update Posted : June 8, 2011
|Condition or disease||Intervention/treatment||Phase|
|Renal Diseases||Drug: Levofloxacin||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||59 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||An Open-Label Randomized Multiple-Dose Study to Evaluate Levofloxacin Steady-State Pharmacokinetics and Safety in Subjects With Varying Degrees of Renal Function|
|Study Start Date :||October 2004|
|Study Completion Date :||April 2006|
- Evaluation of the pharmacokinetics of two dosing regimens of levofloxacin in renally impaired and dialysis patients.
- Safety of two dosing regimens of levofloxacin in renally impaired and dialysis patients.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00645437
|Study Director:||Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|